Gushengtang Holdings Limited (HK:2273)
:2273
Want to see HK:2273 full AI Analyst Report?
2273 Stock Chart & Stats
HK$29.00
HK$0.95(3.47%)
At close: 4:00 PM EST
HK$29.00
HK$0.95(3.47%)
Day’s Range― - ―
52-Week RangeHK$25.00 - HK$38.30
Previous CloseN/A
Volume1.49M
Average Volume (3M)1.54M
Market Cap
HK$6.49B
Enterprise ValueHK$4.93B
Total Cash (Recent Filing)HK$1.15B
Total Debt (Recent Filing)HK$784.51M
Price to Earnings (P/E)16.1
Beta1.24
Next Earnings
Aug 25, 2026EPS Estimate
0.87Next Dividend Ex-DateN/A
Dividend Yield2.61%
Share Statistics
EPS (TTM)1.49
Shares Outstanding234,371,050
10 Day Avg. Volume1,228,922
30 Day Avg. Volume1,539,754
Financial Highlights & Ratios
PEG Ratio0.96
Price to Book (P/B)2.84
Price to Sales (P/S)1.90
P/FCF Ratio12.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$38.53Price Target Upside32.88% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
EPS Forecast (FY)1.81
Revenue Forecast (FY)HK$3.75B
Bulls Say, Bears Say
Bulls Say
Post-2021 Profitable Turnaround And Revenue AccelerationThe company shifted from a 2021 loss into consistent profitability from 2022 onward, with rapid revenue acceleration in 2024–2025. That durable earnings recovery and top-line momentum support reinvestment in clinics and sustainable service expansion over the medium term.
Sound Balance Sheet With Moderate Leverage And Improving ROEModerate leverage (D/E ~0.36 in 2025) and rising ROE indicate the company retains financial flexibility while generating stronger returns on shareholder capital. A reasonable asset and equity base supports network growth and reduces likelihood of acute refinancing risk in the near term.
Consistent Positive Operating And Free Cash Flow GenerationAcross 2022–2025 FCF has been meaningfully positive and tracks a large portion of reported earnings (~0.80–0.87), signaling genuine cash conversion. Predictable cash generation supports clinic reinvestment, modest dividends, and reduces dependency on external funding for growth.
Bears Say
Sharp 2025 Free Cash Flow Decline And Operating Cash VolatilityA sharp drop in FCF growth in 2025 and persistent operating cash coverage near 50–60% of earnings point to timing swings or working-capital pressure. These dynamics can constrain reinvestment and raise sensitivity to slower patient volumes or payment delays over the medium term.
Margin And EBITDA VolatilityWhile net margins are positive, variability in gross and EBITDA margins indicates inconsistent cost control, mix shifts, or pricing pressures. Persistent margin volatility undermines operating leverage and makes long-term margin forecasts and free-cash-flow stability less reliable.
Leverage Trend Rising In 2025 Versus Prior YearsAlthough leverage remains moderate, the increase in debt in 2025 reduces headroom for additional borrowing and raises refinancing and interest-rate exposure. If growth slows or cash flow weakens, higher leverage could limit strategic options and increase financial strain.
Gushengtang Holdings Limited News
2273 FAQ
What was Gushengtang Holdings Limited’s price range in the past 12 months?
Gushengtang Holdings Limited lowest stock price was HK$25.00 and its highest was HK$38.30 in the past 12 months.
What is Gushengtang Holdings Limited’s market cap?
Gushengtang Holdings Limited’s market cap is HK$6.49B.
When is Gushengtang Holdings Limited’s upcoming earnings report date?
Gushengtang Holdings Limited’s upcoming earnings report date is Aug 25, 2026 which is in 69 days.
How were Gushengtang Holdings Limited’s earnings last quarter?
Gushengtang Holdings Limited released its earnings results on Mar 31, 2026. The company reported HK$1.124 earnings per share for the quarter, beating the consensus estimate of HK$1.079 by HK$0.046.
Is Gushengtang Holdings Limited overvalued?
According to Wall Street analysts Gushengtang Holdings Limited’s price is currently Undervalued.
Does Gushengtang Holdings Limited pay dividends?
Gushengtang Holdings Limited pays a Quarterly dividend of HK$0.69 which represents an annual dividend yield of 2.61%. See more information on Gushengtang Holdings Limited dividends here
What is Gushengtang Holdings Limited’s EPS estimate?
Gushengtang Holdings Limited’s EPS estimate is 0.87.
How many shares outstanding does Gushengtang Holdings Limited have?
Gushengtang Holdings Limited has 234,371,050 shares outstanding.
What happened to Gushengtang Holdings Limited’s price movement after its last earnings report?
Gushengtang Holdings Limited reported an EPS of HK$1.124 in its last earnings report, beating expectations of HK$1.079. Following the earnings report the stock price went down -0.51%.
Which hedge fund is a major shareholder of Gushengtang Holdings Limited?
Currently, no hedge funds are holding shares in HK:2273
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Gushengtang Holdings Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.49%
12-Months-Change
Fundamentals
Return on Equity
15.51%
Trailing 12-Months
Asset Growth
14.29%
Trailing 12-Months
Company Description
Gushengtang Holdings Limited
Gushengtang Holdings Limited functions as an investment holding company, primarily engaged in offering healthcare services and distributing health-related products. The company's operations also encompass the wholesale and retail trade of pharmaceutical goods, in addition to providing investment management and supply chain management solutions. Established in 2014, the entity was initially known as Gushengtang (Cayman) Ltd. until it rebranded to Gushengtang Holdings Limited in September 2021. Its corporate headquarters are situated in Guangzhou, China.
2273 Stock 12 Month Forecast
Average Price Target
HK$38.53
▲(32.88% Upside)
Technical Analysis
Beauty Farm Medical & Health Industry, Inc.
―
C-MER Eye Care Holdings Limited
―
Town Health International Medical Group Ltd.
―
Hygeia Healthcare Holdings Co., Ltd.
―
Arrail Group Ltd.
―
Options Prices
Currently, No data available
---